Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System Lymphoma
Clinical trial NCT04934579 · COMPLETED
Trial details
- NCT number
- NCT04934579
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2022-10-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.